A sudden shift in understanding or perspective that feels true—called insight—is common during psychedelic experiences and is often considered central to their therapeutic value. A systematic review of 98 studies (40 survey, 58 interventional) found that insight was positively correlated with psychedelic dose and was significantly higher after psychedelics in 93% of studies comparing to placebo. Crucially, 86% of studies found that insight was associated with therapeutic improvement, and this relationship was often stronger than that of mystical-type experience. The findings suggest insight's importance for clinical practice and understanding mechanisms of psychedelic therapy, though heterogeneous study designs and possible publication bias limit meta-analytic conclusions.
Insights—sudden, subjectively true understandings—are common during psychedelic experiences and are often considered central to therapy, but their role had not been systematically assessed. This systematic review of 98 studies found that psychedelic-catalyzed insight (PCI) was positively correlated with dose and was statistically significant in 93% of studies comparing psychedelic to placebo. Crucially, 86% of studies found PCI associated with positive therapeutic outcomes, often more strongly than mystical-type experiences. The findings suggest PCI is an important topic for clinical psychedelic therapy and for understanding mechanisms of psychedelic therapy.